Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST
SHA:600664 Revenue
Harbin Pharmaceutical Group had revenue of 4.18B CNY in the quarter ending March 31, 2026, with 0.02% growth. This brings the company's revenue in the last twelve months to 15.96B, down -1.50% year-over-year. In the year 2025, Harbin Pharmaceutical Group had annual revenue of 15.96B, down -1.31%.
Revenue (ttm)
15.96B
Revenue Growth
-1.50%
P/S Ratio
0.58
Revenue / Employee
1.57M
Employees
10,180
Market Cap
9.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.96B | -211.79M | -1.31% |
| Dec 31, 2024 | 16.18B | 719.28M | 4.65% |
| Dec 31, 2023 | 15.46B | 1.65B | 11.93% |
| Dec 31, 2022 | 13.81B | 1.01B | 7.86% |
| Dec 31, 2021 | 12.80B | 2.01B | 18.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition